Copyright
©The Author(s) 2019.
World J Gastroenterol. Jul 28, 2019; 25(28): 3684-3703
Published online Jul 28, 2019. doi: 10.3748/wjg.v25.i28.3684
Published online Jul 28, 2019. doi: 10.3748/wjg.v25.i28.3684
Diagnosis | Definition |
Acute kidney injury (AKI) | Rise in serum creatinine (SCr) of ≥ 50% from baseline or a rise in SCr by ≥ 0.3 mg/dL (26.5 μmol/L) in < 48 h. Hepatorenal syndrome (HRS) type 1 is a specific form of AKI |
Stage 1: Increase in serum creatinine (SCr) ≥ 0.3 mg/dL (26.5 μmol/L) or an increase in SCr 1.5-fold to 2-fold from baseline | |
Stage 2: Increase in SCr > 2-fold to 3-fold from baseline | |
Stage 3: Increase in SCr > 3-fold from baseline or an increase in SCr ≥ 4.0 mg/dL (353.6 μmol/L) with an acute increase ≥ 0.3 mg/dL (26.5 μmol/L) or initiation of renal replacement therapy | |
Chronic kidney disease (CKD) | Glomerular filtration rate (GFR) of < 60 mL/min for > 3 mo, calculated using the MDRD6 formula. HRS type 2 is a specific form of CKD |
Acute-on-chronic kidney disease | Rise in SCr of ≥ 50% from baseline or a rise of SCr by ≥ 0.3 mg/dL (26.5 μmol/L) in < 48 h in a patient with cirrhosis whose GFR is < 60 mL/min for > 3 mo, calculated using the MDRD6 formula |
- Citation: Chancharoenthana W, Leelahavanichkul A. Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand? World J Gastroenterol 2019; 25(28): 3684-3703
- URL: https://www.wjgnet.com/1007-9327/full/v25/i28/3684.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i28.3684